Reuters logo
BRIEF-Axsome Therapeutics Announces AXS-07 For The Treatment Of Migraine
November 28, 2017 / 12:14 PM / 16 days ago

BRIEF-Axsome Therapeutics Announces AXS-07 For The Treatment Of Migraine

Nov 28 (Reuters) - Axsome Therapeutics Inc:

* AXSOME THERAPEUTICS ANNOUNCES AXS-07 FOR THE TREATMENT OF MIGRAINE

* AXSOME THERAPEUTICS INC - ‍PHASE 3 TRIAL ANTICIPATED IN 2018​

* AXSOME THERAPEUTICS INC - AXS-07 HAS ‍POTENTIAL FOR “SUPERIOR” EFFICACY AS COMPARED TO CURRENT TREATMENTS​

* AXSOME THERAPEUTICS INC - ‍U.S. FDA PRE-INVESTIGATIONAL NEW DRUG APPLICATION​ MEETING WRITTEN GUIDANCE RECEIVED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below